Biotinylated Cynomolgus TNF-alpha Protein, His,Avitag™, active trimer (MALS verified)

ユーザーレビュー
製品番号/仕様
価格
数量
TNA-C82E3-25ug
$360.00
TNA-C82E3-200ug
$1565.00
ETA of in-stock products:2 business days
総アイテム数 製品金額$ 0

製品詳細

  • Synonyms

    DIF, TNF-alpha, TNFA, TNFSF2, cachexin, cachectin, TNFα

  • Source

    Biotinylated Cynomolgus TNF-alpha Protein, His,Avitag, active trimer (TNA-C82E3) is expressed from human 293 cells (HEK293). It contains AA Val 77 - Leu 233 (Accession # P79337).

    Predicted N-terminus: Val 77

    Request for sequence
  • Molecular Characterization

    TNF-alpha Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag™).

    The protein has a calculated MW of 20.8 kDa. The protein migrates as 22-24 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

    The protein is designed as a trimer.

  • Labeling

    Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

  • Protein Ratio

    Passed as determined by the HABA assay / binding ELISA.

  • Purity

    >95% as determined by SDS-PAGE.

    >90% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

お客様はこちらも閲覧

データ表示

  • SDS-PAGE

    TNF-alpha SDS-PAGE

    Biotinylated Cynomolgus TNF-alpha Protein, His,Avitag, active trimer on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    TNF-alpha SEC-MALS

    The purity of Biotinylated Cynomolgus TNF-alpha Protein, His,Avitag, active trimer (Cat. No. TNA-C82E3) is more than 90% and the molecular weight of this protein is around 55-70 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     TNF-alpha ELISA

    Immobilized Cynomolgus / Rhesus macaque TNFR2, His Tag (Cat. No. TN2-C52H7) at 5 μg/mL (100 μL/well) can bind Biotinylated Cynomolgus TNF-alpha Protein, His,Avitag, active trimer (Cat. No. TNA-C82E3) with a linear range of 0.06-2 ng/mL (QC tested).

    Protocol
  •  TNF-alpha ELISA

    Immobilized Human TNFR1, Fc Tag (Cat. No. TN1-H5251) at 5 μg/mL (100 μL/well) can bind Biotinylated Cynomolgus TNF-alpha Protein, His,Avitag, active trimer (Cat. No. TNA-C82E3) with a linear range of 0.06-2 ng/mL (Routinely tested).

    Protocol

ユーザーレビュー
コメントを投稿

バックグランド

Tumor necrosis factor alpha (TNFα) is a cytokine produced primarily by monocytes and macrophages. It is found in synovial cells and macrophages in the tissues.The primary role of TNFα is in the regulation of immune cells. TNFα is able to induce apoptotic cell death, to induce inflammation, and to inhibit tumorigenesis and viral replication. Dysregulation of TNFα production has been implicated in a variety of human diseases, including major depression, Alzheimer's disease and cancer. Recombinant TNFα is used as an immunostimulant under the INN tasonermin. TNFα can be produced ectopically in the setting of malignancy and parallels parathyroid hormone both in causing secondary hypercalcemia and in the cancers with which excessive production is associated.

最新の進展

 
医薬品開発の進捗
  • 英語名:

    Tumor necrosis factor α

  • カテゴリ:

  • 市販の医薬品数:

    68 詳細

  • 治験医薬品数:

    74 詳細

  • 最新の開発ステージ:

    Approved

お問い合わせ
医薬品候補ライセンス
他の関連情報
  • 製品情報
  • 製品詳細
  • お客様はこちらも閲覧
  • データ表示
  • ユーザーレビュー
  • 背景
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8